BCL6A is also considered oncogenic, being highly expressed in many B cell lymphomas such as diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) (Wagner et al., 2011; Green et al., 2014). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.